Lista de obras -

A phase I trial of adeno-associated virus serotype 1-γ-sarcoglycan gene therapy for limb girdle muscular dystrophy type 2C.

artículo científico publicado en 2012

Abatacept for Severe Immune Checkpoint Inhibitor-Associated Myocarditis

artículo científico publicado en 2019

Acquired necrotizing myopathies

artículo científico publicado en 2012

Activated dendritic cells modulate proliferation and differentiation of human myoblasts.

artículo científico publicado en 2018

Advances in serological diagnostics of inflammatory myopathies

artículo científico publicado en 2016

Analysis of cell surface and intranuclear markers on non-stimulated human PBMC using mass cytometry.

artículo científico publicado en 2018

Anti-HMGCR autoantibodies in European patients with autoimmune necrotizing myopathies: inconstant exposure to statin

artículo científico publicado en 2014

Anti-HMGCR myopathy may resemble limb-girdle muscular dystrophy

artículo científico publicado en 2018

Anti-Jo-1 antibody-positive patients show a characteristic necrotizing perifascicular myositis.

artículo científico publicado en 2015

Anti-mitochondrial antibodies are not a hallmark of severity in idiopathic inflammatory myopathies

artículo científico publicado en 2017

Antisynthetase Syndrome with Anti-Jo1 Antibodies in 48 Patients: Pulmonary Involvement Predicts Disease-modifying Antirheumatic Drug Use

scientific article published on 01 August 2012

Architectural B-cell organization in skeletal muscle identifies subtypes of dermatomyositis.

artículo científico publicado en 2018

Autoantibodies at the Center of (sub)Classification-Issues of Detection-Reply

scientific article published on 01 July 2019

Autoantibodies in idiopathic inflammatory myopathies: Clinical associations and laboratory evaluation by mono- and multispecific immunoassays

artículo científico publicado en 2019

Beneficial role of rapamycin in experimental autoimmune myositis

artículo científico publicado en 2013

CD49d is a disease progression biomarker and a potential target for immunotherapy in Duchenne muscular dystrophy

artículo científico publicado en 2015

CD8+T-bet+ cells as a predominant biomarker for inclusion body myositis

scientific article published on 28 February 2019

Comparison of MR T1 and T2 mapping parameters to characterize myocardial and skeletal muscle involvement in systemic idiopathic inflammatory myopathy (IIM)

artículo científico publicado en 2019

Correction: Beneficial Role of Rapamycin in Experimental Autoimmune Myositis.

artículo científico publicado en 2014

Correspondence on 'Impact of COVID-19 pandemic on patients with large-vessels vasculitis in Italy: a monocentric survey'

artículo científico publicado en 2020

Dermatomyositis With or Without Anti-Melanoma Differentiation-Associated Gene 5 Antibodies: Common Interferon Signature but Distinct NOS2 Expression.

artículo científico publicado en 2016

Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies

scientific article published on 01 December 2018

Diagnostic Utility of Auto-Antibodies in Inflammatory Muscle Diseases.

artículo científico publicado en 2015

Diagnostic potential of sarcoplasmic myxovirus resistance protein A expression in subsets of dermatomyositis

scientific article published on 22 November 2018

Diagnostic value of markers of muscle degeneration in sporadic inclusion body myositis.

artículo científico publicado en 2011

Different phenotypes in dermatomyositis associated with anti-MDA5 antibody: Study of 121 cases

scientific article published on 02 June 2020

Differential roles of hypoxia and innate immunity in juvenile and adult dermatomyositis

artículo científico publicado en 2016

EULAR points to consider for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy with checkpoint inhibitors

scientific article published on 23 April 2020

Efficacy of Rituximab in Refractory Generalized anti-AChR Myasthenia Gravis

artículo científico publicado en 2018

Efficacy of Rituximab in Refractory Inflammatory Myopathies Associated with Anti- Synthetase Auto-Antibodies: An Open-Label, Phase II Trial

artículo científico publicado en 2015

Expanding the spectrum of HIV-associated myopathy

scientific article published on 11 April 2019

Expanding the spectrum of livedoid vasculopathy: peculiar neuromuscular manifestations.

artículo científico publicado en 2015

Exploring necrotizing autoimmune myopathies with a novel immunoassay for anti-3-hydroxy-3-methyl-glutaryl-CoA reductase autoantibodies.

artículo científico publicado en 2014

Focal myositis: An unknown disease

artículo científico publicado en 2017

Four-year longitudinal study of clinical and functional endpoints in sporadic inclusion body myositis: implications for therapeutic trials

artículo científico publicado en 2014

French expert opinion for the management of juvenile dermatomyositis

scientific article published on 10 January 2019

Granulomatosis-associated myositis: High prevalence of sporadic inclusion body myositis

artículo científico publicado en 2019

High frequency of venous thromboembolic events in Churg-Strauss syndrome, Wegener's granulomatosis and microscopic polyangiitis but not polyarteritis nodosa: a systematic retrospective study on 1130 patients

artículo científico publicado en 2008

High risk of cancer in autoimmune necrotizing myopathies: usefulness of myositis specific antibody.

artículo científico publicado en 2016

IFN-β-induced reactive oxygen species and mitochondrial damage contribute to muscle impairment and inflammation maintenance in dermatomyositis

artículo científico publicado en 2017

Immune Checkpoint Inhibitor-Associated Myositis

artículo científico publicado en 2018

Immune checkpoint inhibitor-related myositis and myocarditis in patients with cancer

artículo científico publicado en 2018

Inclusion body myositis: accumulation of evidence for its autoimmune origin

scientific article published on 01 September 2019

Infliximab as effective treatment for aseptic neutrophilic myositis

scientific article published on 29 October 2019

Integrated classification of inflammatory myopathies

artículo científico publicado en 2017

Interleukin-21 modulates Th1 and Th17 responses in giant cell arteritis

article

Involvement of NK Cells and NKp30 Pathway in Antisynthetase Syndrome

artículo científico publicado en 2016

JAK inhibitor improves type I interferon induced damage: proof of concept in dermatomyositis

scientific article published on 01 June 2018

Long-term observational study of sporadic inclusion body myositis.

artículo científico publicado en 2011

Mass cytometry reveals an impairment of B cell homeostasis in anti-synthetase syndrome

artículo científico publicado en 2019

Muscle Shear Wave Elastography in Inclusion Body Myositis: Feasibility, Reliability and Relationships with Muscle Impairments

artículo científico publicado en 2018

Myocarditis in the Setting of Cancer Therapeutics: Proposed Case Definitions for Emerging Clinical Syndromes in Cardio-Oncology

scientific article published on 01 July 2019

Myositis-specific autoantibodies, a cornerstone in immune-mediated necrotizing myopathy

scientific article published on 11 January 2019

Necrosis in anti-SRP+ and anti-HMGCR+myopathies: Role of autoantibodies and complement

artículo científico publicado en 2018

Non-invasive differentiation of idiopathic inflammatory myopathy with cardiac involvement from acute viral myocarditis using cardiovascular magnetic resonance imaging T1 and T2 mapping.

artículo científico publicado en 2018

Nuclear actin aggregation is a hallmark of anti-synthetase syndrome-induced dysimmune myopathy.

artículo científico publicado en 2015

PD1 pathway in immune-mediated myopathies: Pathogenesis of dysfunctional T cells revisited

scientific article published on 10 April 2019

Pathogenic role of anti-signal recognition protein and anti-3-Hydroxy-3-methylglutaryl-CoA reductase antibodies in necrotizing myopathies: Myofiber atrophy and impairment of muscle regeneration in necrotizing autoimmune myopathies.

artículo científico publicado en 2017

Peculiar clinicopathological features of immune-mediated necrotizing myopathies

scientific article published on 01 November 2018

Physical activity monitoring: A promising outcome measure in idiopathic inflammatory myopathies.

artículo científico publicado en 2017

Potential Pathogenic Role of Anti-Signal Recognition Protein and Anti-3-hydroxy-3-methylglutaryl-CoA Reductase Antibodies in Immune-Mediated Necrotizing Myopathies

artículo científico publicado en 2018

Proximal weakness in a patient with MALT lymphoma: a case report and discussion of possible pathogenesis.

artículo científico publicado en 2015

Quadriceps strength is a sensitive marker of disease progression in sporadic inclusion body myositis.

artículo científico publicado en 2012

Reply: A child with severe juvenile dermatomyositis treated with ruxolitinib

scientific article published on 01 November 2018

Reply: Janus kinase 1/2 inhibition with baricitinib in the treatment of juvenile dermatomyositis

artículo científico publicado en 2019

Reply: Perifascicular necrosis in anti-synthetase syndrome beyond anti-Jo-1.

artículo científico publicado en 2016

Reply: Treatment of anti-MDA5 autoantibody-positive juvenile dermatomyositis using tofacitinib

artículo científico publicado en 2019

Response to: 'On using machine learning algorithms to define clinically meaningful patient subgroups' by Pinal-Fernandez and Mammen

artículo científico publicado en 2019

Responsiveness to Change of 5-point MRC scale, Endurance and Functional Evaluation for Assessing Myositis in Daily Clinical Practice

artículo científico publicado en 2019

Rituximab in the Treatment of Refractory Anti-HMGCR Immune-mediated Necrotizing Myopathy

artículo científico publicado en 2018

Sequestosome-1 (p62) expression reveals chaperone-assisted selective autophagy in immune-mediated necrotizing myopathies

artículo científico publicado en 2019

Sirolimus and mTOR Inhibitors: A Review of Side Effects and Specific Management in Solid Organ Transplantation

artículo científico publicado en 2019

Synthesis and in vitro evaluation of tropane halogenated-derivatives against malaria, sleeping sickness, Chagas disease and leishmaniasis

artículo científico publicado en 2014

Th1 response and systemic treg deficiency in inclusion body myositis.

artículo científico publicado en 2014

Th2-M2 immunity in lesions of muscular sarcoidosis and macrophagic myofasciitis.

artículo científico publicado en 2015

The IgG2 Isotype of Anti-Transcription Intermediary Factor 1γ Autoantibodies Is a Biomarker of Cancer and Mortality in Adult Dermatomyositis

artículo científico publicado en 2019

Usefulness of autoantibodies for the diagnosis of autoimmune myopathies

artículo científico publicado en 2013

Value of magnetic resonance imaging for evaluating muscle inflammation: insights from a new mouse model of myositis

artículo científico publicado en 2017

[Autoantibody profile in myositis].

artículo científico publicado en 2014

pathogenicity of IgG from patients with anti-SRP or anti-HMGCR autoantibodies in immune-mediated necrotising myopathy

scientific article published on 11 October 2018

Lista de obras de

A phase I trial of adeno-associated virus serotype 1-γ-sarcoglycan gene therapy for limb girdle muscular dystrophy type 2C.

Abatacept for Severe Immune Checkpoint Inhibitor-Associated Myocarditis

Acquired necrotizing myopathies

Activated dendritic cells modulate proliferation and differentiation of human myoblasts.

Advances in serological diagnostics of inflammatory myopathies

Analysis of cell surface and intranuclear markers on non-stimulated human PBMC using mass cytometry.

Anti-HMGCR autoantibodies in European patients with autoimmune necrotizing myopathies: inconstant exposure to statin

Anti-HMGCR myopathy may resemble limb-girdle muscular dystrophy

Anti-Jo-1 antibody-positive patients show a characteristic necrotizing perifascicular myositis.

Anti-mitochondrial antibodies are not a hallmark of severity in idiopathic inflammatory myopathies

Antisynthetase Syndrome with Anti-Jo1 Antibodies in 48 Patients: Pulmonary Involvement Predicts Disease-modifying Antirheumatic Drug Use

Architectural B-cell organization in skeletal muscle identifies subtypes of dermatomyositis.

Autoantibodies at the Center of (sub)Classification-Issues of Detection-Reply

Autoantibodies in idiopathic inflammatory myopathies: Clinical associations and laboratory evaluation by mono- and multispecific immunoassays

Beneficial role of rapamycin in experimental autoimmune myositis

CD49d is a disease progression biomarker and a potential target for immunotherapy in Duchenne muscular dystrophy

CD8+T-bet+ cells as a predominant biomarker for inclusion body myositis

Comparison of MR T1 and T2 mapping parameters to characterize myocardial and skeletal muscle involvement in systemic idiopathic inflammatory myopathy (IIM)

Correction: Beneficial Role of Rapamycin in Experimental Autoimmune Myositis.

Correspondence on 'Impact of COVID-19 pandemic on patients with large-vessels vasculitis in Italy: a monocentric survey'

Dermatomyositis With or Without Anti-Melanoma Differentiation-Associated Gene 5 Antibodies: Common Interferon Signature but Distinct NOS2 Expression.

Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies

Diagnostic Utility of Auto-Antibodies in Inflammatory Muscle Diseases.

Diagnostic potential of sarcoplasmic myxovirus resistance protein A expression in subsets of dermatomyositis

Diagnostic value of markers of muscle degeneration in sporadic inclusion body myositis.

Different phenotypes in dermatomyositis associated with anti-MDA5 antibody: Study of 121 cases

Differential roles of hypoxia and innate immunity in juvenile and adult dermatomyositis

EULAR points to consider for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy with checkpoint inhibitors

Efficacy of Rituximab in Refractory Generalized anti-AChR Myasthenia Gravis

Efficacy of Rituximab in Refractory Inflammatory Myopathies Associated with Anti- Synthetase Auto-Antibodies: An Open-Label, Phase II Trial

Expanding the spectrum of HIV-associated myopathy

Expanding the spectrum of livedoid vasculopathy: peculiar neuromuscular manifestations.

Exploring necrotizing autoimmune myopathies with a novel immunoassay for anti-3-hydroxy-3-methyl-glutaryl-CoA reductase autoantibodies.

Focal myositis: An unknown disease

Four-year longitudinal study of clinical and functional endpoints in sporadic inclusion body myositis: implications for therapeutic trials

French expert opinion for the management of juvenile dermatomyositis

Granulomatosis-associated myositis: High prevalence of sporadic inclusion body myositis

High frequency of venous thromboembolic events in Churg-Strauss syndrome, Wegener's granulomatosis and microscopic polyangiitis but not polyarteritis nodosa: a systematic retrospective study on 1130 patients

High risk of cancer in autoimmune necrotizing myopathies: usefulness of myositis specific antibody.

IFN-β-induced reactive oxygen species and mitochondrial damage contribute to muscle impairment and inflammation maintenance in dermatomyositis

Immune Checkpoint Inhibitor-Associated Myositis

Immune checkpoint inhibitor-related myositis and myocarditis in patients with cancer

Inclusion body myositis: accumulation of evidence for its autoimmune origin

Infliximab as effective treatment for aseptic neutrophilic myositis

Integrated classification of inflammatory myopathies

Interleukin-21 modulates Th1 and Th17 responses in giant cell arteritis

Involvement of NK Cells and NKp30 Pathway in Antisynthetase Syndrome

JAK inhibitor improves type I interferon induced damage: proof of concept in dermatomyositis

Long-term observational study of sporadic inclusion body myositis.

Mass cytometry reveals an impairment of B cell homeostasis in anti-synthetase syndrome

Muscle Shear Wave Elastography in Inclusion Body Myositis: Feasibility, Reliability and Relationships with Muscle Impairments

Myocarditis in the Setting of Cancer Therapeutics: Proposed Case Definitions for Emerging Clinical Syndromes in Cardio-Oncology

Myositis-specific autoantibodies, a cornerstone in immune-mediated necrotizing myopathy

Necrosis in anti-SRP+ and anti-HMGCR+myopathies: Role of autoantibodies and complement

Non-invasive differentiation of idiopathic inflammatory myopathy with cardiac involvement from acute viral myocarditis using cardiovascular magnetic resonance imaging T1 and T2 mapping.

Nuclear actin aggregation is a hallmark of anti-synthetase syndrome-induced dysimmune myopathy.

PD1 pathway in immune-mediated myopathies: Pathogenesis of dysfunctional T cells revisited

Pathogenic role of anti-signal recognition protein and anti-3-Hydroxy-3-methylglutaryl-CoA reductase antibodies in necrotizing myopathies: Myofiber atrophy and impairment of muscle regeneration in necrotizing autoimmune myopathies.

Peculiar clinicopathological features of immune-mediated necrotizing myopathies

Physical activity monitoring: A promising outcome measure in idiopathic inflammatory myopathies.

Potential Pathogenic Role of Anti-Signal Recognition Protein and Anti-3-hydroxy-3-methylglutaryl-CoA Reductase Antibodies in Immune-Mediated Necrotizing Myopathies

Proximal weakness in a patient with MALT lymphoma: a case report and discussion of possible pathogenesis.

Quadriceps strength is a sensitive marker of disease progression in sporadic inclusion body myositis.

Reply: A child with severe juvenile dermatomyositis treated with ruxolitinib

Reply: Janus kinase 1/2 inhibition with baricitinib in the treatment of juvenile dermatomyositis

Reply: Perifascicular necrosis in anti-synthetase syndrome beyond anti-Jo-1.

Reply: Treatment of anti-MDA5 autoantibody-positive juvenile dermatomyositis using tofacitinib

Response to: 'On using machine learning algorithms to define clinically meaningful patient subgroups' by Pinal-Fernandez and Mammen

Responsiveness to Change of 5-point MRC scale, Endurance and Functional Evaluation for Assessing Myositis in Daily Clinical Practice

Rituximab in the Treatment of Refractory Anti-HMGCR Immune-mediated Necrotizing Myopathy

Sequestosome-1 (p62) expression reveals chaperone-assisted selective autophagy in immune-mediated necrotizing myopathies

Sirolimus and mTOR Inhibitors: A Review of Side Effects and Specific Management in Solid Organ Transplantation

Synthesis and in vitro evaluation of tropane halogenated-derivatives against malaria, sleeping sickness, Chagas disease and leishmaniasis

Th1 response and systemic treg deficiency in inclusion body myositis.

Th2-M2 immunity in lesions of muscular sarcoidosis and macrophagic myofasciitis.

The IgG2 Isotype of Anti-Transcription Intermediary Factor 1γ Autoantibodies Is a Biomarker of Cancer and Mortality in Adult Dermatomyositis

Usefulness of autoantibodies for the diagnosis of autoimmune myopathies

Value of magnetic resonance imaging for evaluating muscle inflammation: insights from a new mouse model of myositis

[Autoantibody profile in myositis].